Skip to content

Physiological Response to Salbutamol and Exercise

Physiological Response to Salbutamol and Exercise

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03902106
Enrollment
40
Registered
2019-04-03
Start date
2019-03-28
Completion date
2021-06-30
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The scope of the study is to investigate the physiological response to salbutamol and exercise. A particular focus is on the metabolic response and amine metabolism.

Interventions

DRUGsalbutamol

subjects ingest salbutamol

OTHERexercise

subjects undergo 6 weeks of endurance training (3 times weekly)

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * VO2max of \>55 ml/min/kg for men and \>50 ml/min/kg for women * Body mass index (BMI) \< 26

Exclusion criteria

* Chronic use of beta2-agonist or allergy towards beta2-agonist * Serious adverse effects to beta2-agonist * Chronic disease deemed by the study responsible medical doctor to interfere with any part of the study * Smoking * Chronic use of prescription medicine deemed by the study responsible medical doctor to interfere with any part of the study * Pregnancy (for women)

Design outcomes

Primary

MeasureTime frameDescription
Body compositionBaseline, 2 weeks, 4 weeks and 6 weeksChange in body composition (measured by dual energy x ray absorptiometry)
Maximal oxygen consumption (VO2max)Baseline, 2 weeks, 4 weeks and 6 weeksChange in VO2max (measured during bike ergometer cycling to exhaustion)

Secondary

MeasureTime frameDescription
Salbutamol urine concentrationBefore (baseline) as well as 0-1 hours, 1-2 hours, 2-4 hours, 4-8 hours, and 8-16 hours after administrationConcentration of salbutamol in urine

Other

MeasureTime frameDescription
Muscle strengthBaseline, 2 weeks, 4 weeks and 6 weeksIsometric muscle force of the quadriceps

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026